In this article, we present a unique story: that of a child whom CBD is said to have saved from a tumor. This story will serve as a springboard for exploring a complex and increasingly prevalent disease affecting children. We will then examine the growing interest in cannabidiol.
Summary
ToggleThe summary
The story in a few words
Indeed, we are in England. Four-year-old William Frost suffers from a rare brain tumor that is slowly consuming him. After examining the boy in 2014, an MRI revealed a rare, cancerous tumor the size of a golf ball in William's brain.
The doctors opted for conventional aggressive treatments in an attempt to save him. Nothing worked. They tried surgery, but there was no change. The little boy gradually faded away. As a last resort, chemotherapy was used, but without success. These interventions also left him paralyzed. The tumor seemed to subside, then returned with renewed vigor. The doctors announced that the child was going to die, since no treatment seemed to be working.
The little boy's parents are not ready to lose him in the prime of his life. He's only 4 years old! That's why they decided to try a treatment based onCBD oil, derived from cannabis. They had heard that it might help. The mother stated:
"We decided to seek treatment outside the healthcare system and we obtained cannabidiol (CBD)."
This was followed by six months of treatment: a ketogenic diet (very low in carbohydrates) and CBD administration. The parents' first observation was the improvement in William's condition. The tumor had shrunk and stopped growing. The mother was able to speak again.
"Even though we defied fate, so far the tumor is in a stable state, which means it is no longer growing.".
She concluded.
"The CBD given to William, alongside the ketogenic diet, had a remarkable impact on William's recovery.".
In fact, this story allows us to put the issue of cancer, and brain tumors in particular, back on the table.
Some statistics on this tumor
Indeed, far from the spotlight, brain tumors are practically killing our children and younger siblings every day. In fact, in England, for example, approximately 1,750 individuals under the age of 18 are diagnosed with cancer each year. Around 400 of these are brain and spinal cord cancers. It should be noted that this type of tumor is the leading cause of cancer death in the country.
This finding is alarming and raises questions about current conventional treatments, particularly their effectiveness against such aggressive diseases. High-quality treatment is urgently needed to save lives. Moreover, we are not alone in this view. The lead researcher, Professor Richard Grundy, from the University of Nottingham's Children's Brain Tumor Centre, shares this opinion. He stated...
“New ways to treat brain tumors in children are urgently needed to extend and improve the quality of life for patients with malignant brain tumors. So we are excited to test the effect of cannabidiol (CBD) on brain tumor cells.”.
Professor Richard Grundy's study
Indeed, it would undoubtedly be one of the leading studies of its kind. That being said, what is its purpose? What exactly does it involve? Essentially, the goal is to determine if CBD reduces tumors. To achieve this, the researchers have a very specific process. Cells from different brain tumors will be cultured under laboratory conditions. Some will be cultured with cannabidiol molecules, and others without. Afterward, they will compare the two samples using a technique called cell staining. This will allow them to see if the cells divide and die.
In line with this, Professor Grundy is already outlining their expectations.
"We expect the cells – both the brain tumor and normal brain cells – under our standard conditions to be healthy and actively dividing. We expect normal brain cells cultured in cannabidiol to remain healthy. However, we expect brain tumor cells cultured in cannabidiol to stop growing and die.".
References
- https://www.blog-cannabis.com/cbd-enfant-tumeur-cerebrale-rare/
Co-founder of CBD.fr
Julien Cordobes is the editor of CBD.fr. Born in 1978 in the Paris region, he first trained in e-commerce before turning to natural health approaches, a dual perspective that now structures his way of writing about cannabidiol: reading the scientific literature as it is, without hardening the conclusions, and presenting it in a language that everyone understands.
He discovered CBD at a time when the French market was developing faster than the information available to it. He acquired CBD.fr in 2022 and then took on editorial responsibility for the blog. Since then, he has published numerous articles covering the daily use of CBD, the interpretation of laboratory analyses, the evolution of the legal framework, and precautions for use.